在抗凝血患者群体中探索电疗法的使用:系统性审查
Ashna Khalid1,2, Aafreen Khalid1,2, Sue Waite1
1Central Adelaide Local Health Network, The Queen Elizabeth Hospital, Woodville, SA, Australia.
The Australian and New Zealand journal of psychiatry
|September 10, 2024
概括
抗凝治疗患者的电疗法 (ECT) 一般耐受良好,在继续抗凝治疗时报告的不良事件很少. 需要进一步的研究来制定最终的实践指南.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 电疗法 (ECT) 是一种有效的精神病治疗方法.
- 对于接受抗凝治疗的患者,存在理论上的风险.
- 关于ECT对抗凝固药患者的不良影响的数据有限.
研究的目的:
- 在接受抗凝剂治疗的患者中,系统地审查关于电治疗 (ECT) 的文献.
- 为了调查与在ECT期间继续或停止抗凝剂相关的不良影响.
主要方法:
- 在CENTRAL,Embase,Medline和Psychinfo数据库中进行系统的文献搜索.
- 两个独立的审稿人选了标题,摘要和全文,并提取了数据.
- 包括在服用抗凝血药时接受ECT的患者;不包括不相关的论文.
主要成果:
- 审查包括108名患者和700多次ECT会议.
- 华法林是最常见的抗凝剂 (64.81%).
- 发生了两个非致命的出血事件和两个肺栓塞;没有报告内出血或死亡. 桥梁或短效抗凝剂替代没有明显的好处.
结论:
- 在电疗法 (ECT) 期间继续使用抗凝剂似乎通常耐受良好.
- 大多数患者没有出现任何不良反应.
- 由于研究的局限性和需要实践建议,需要进一步的研究.
相关概念视频
Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652


